Ikapharmindo Putramas Tbk. Cash Flow Conversion Efficiency
Ikapharmindo Putramas Tbk. cash flow conversion efficiency. Based on the latest financial reports, Ikapharmindo Putramas Tbk. (IKPM) has a cash flow conversion efficiency ratio of -0.005x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-1.14 Billion ≈ $-66.85K USD) by net assets (Rp236.96 Billion ≈ $13.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Ikapharmindo Putramas Tbk. (2022–2024)
Cash flow conversion efficiency of Ikapharmindo Putramas Tbk. from 2022 to 2024. This chart illustrates how Ikapharmindo Putramas Tbk.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Ikapharmindo Putramas Tbk. for real-time trading data and today's change.
Ikapharmindo Putramas Tbk. Cash Flow Conversion Ratio Explained
Ikapharmindo Putramas Tbk. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Ikapharmindo Putramas Tbk. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ikapharmindo Putramas Tbk. ranked by their cash flow conversion efficiency. Also see market value of Ikapharmindo Putramas Tbk. for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DeepMarkit Corp.
NASDAQ:MKTSF
|
0.168x |
|
Magnum Mining and Exploration Ltd
AU:MGU
|
-0.164x |
|
Huge Group Ltd
JSE:HUG
|
-0.013x |
|
Swoop Holdings Ltd
AU:SWP
|
-0.066x |
|
J D Wetherspoon PLC
LSE:JDW
|
0.175x |
|
Good Times Restaurants Inc
NASDAQ:GTIM
|
0.049x |
|
CMX GOLD+SILVER CORP.
F:6GS
|
-4.784x |
|
FIPP S.A.
PA:FIPP
|
0.002x |
Annual Cash Flow Conversion Efficiency for Ikapharmindo Putramas Tbk. (2022–2024)
The table below shows the annual cash flow conversion efficiency of Ikapharmindo Putramas Tbk. from 2022 to 2024. Review Ikapharmindo Putramas Tbk. free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp246.12 Billion ≈ $14.42 Million |
Rp-33.68 Billion ≈ $-1.97 Million |
-0.137x | -229.09% |
| 2023-12-31 | Rp244.71 Billion ≈ $14.34 Million |
Rp25.94 Billion ≈ $1.52 Million |
0.106x | +399.21% |
| 2022-12-31 | Rp176.70 Billion ≈ $10.35 Million |
Rp3.75 Billion ≈ $219.86K |
0.021x | -- |
About Ikapharmindo Putramas Tbk.
PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in the areas of neurology, psychiatry, dermatology, nephrology, gastroenterology, cardiology, pulmonology, antibiotics, generics, and… Read more